Esomeprazole Magnesium
Product Images NDC 68788-7483

6 FDA label images from Preferred Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 68788-7483). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazole-1 (Esomeprazole 1)

Esomeprazole-1 (Esomeprazole 1)
A line graph titled 'Maintenance of Healing Rates by Month (Study 177)' displaying the percentage of healing maintained over six months. The x-axis represents months from 0 to 6, and the y-axis shows percent maintained from 0 to 100. Four lines represent esomeprazole at doses 40 mg, 20 mg, 10 mg, and placebo, with higher doses showing higher maintenance rates.*
FDA Label Image

Esomeprazole Magnesium Delayed-release Capsules 40mg (Esomeprazole 40mg 30s)

Esomeprazole Magnesium Delayed-release Capsules 40mg (Esomeprazole 40mg 30s)
Label for Esomeprazole Magnesium delayed-release capsules 40mg by Preferred Pharmaceuticals Inc. The label includes dosage information, manufacturer details (Ascend Laboratories, LLC, Parsippany, NJ), and instructions in English and Spanish. It specifies the product as generic for Nexium and provides storage and safety warnings.*
FDA Label Image

Esomeprazole-pic-2 (Esomeprazole Pic 2)

Esomeprazole-pic-2 (Esomeprazole Pic 2)
A line graph titled "Maintenance of Healing Rates by Month (Study 178)" showing percent maintained healing on the y-axis and months (0 to 6) on the x-axis. Four lines represent Esomeprazole 40 mg, 20 mg, 10 mg, and placebo groups, demonstrating that higher doses of Esomeprazole maintain higher healing rates over six months compared to placebo.*
FDA Label Image

Esomeprazole-pic-3 (Esomeprazole Pic 3)

Esomeprazole-pic-3 (Esomeprazole Pic 3)
A line graph titled 'Percent of Patients Symptom-Free of Heartburn by Day (Study 225)' showing three data sets representing Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo over a 28-day diary period. The y-axis indicates the percent of patients symptom-free, and the x-axis is labeled by diary day, illustrating changes in symptom-free patients across the treatment period.*
FDA Label Image

Esomeprazole-pic-4 (Esomeprazole Pic 4)

Esomeprazole-pic-4 (Esomeprazole Pic 4)
A line graph titled 'Percent of Patients Symptom-Free of Heartburn by Day (Study 226)' showing the percentage of patients symptom-free from heartburn over 28 days. It compares three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo, with symptom-free percentages increasing most notably in the Esomeprazole 40 mg group over time.*
FDA Label Image

Esomeprazole-str-1 (Esomeprazole Str 1)

Esomeprazole-str-1 (Esomeprazole Str 1)
Chemical structure of esomeprazole magnesium depicting its molecular composition with magnesium ion complexed to esomeprazole units. The diagram shows the arrangement of atoms and bonds in the esomeprazole molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.